The AF Association announces a collaboration with Boston Scientific Corporation, a global leader in innovative medical technology, to improve awareness of the most common heart rhythm disorder in the world, atrial fibrillation (AF). More than 71 million people across the world are affected by AF[1], which is associated with a high risk of heart failure, cognitive dysfunction, premature death[2] and is the single biggest cardiovascularcause of stroke, increasing risk by up to 500%.[3] AF-related